echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JGH: Thymosin β10 (TMSB10) can be used as a potential prognostic biomarker for the aggressiveness of gastric cancer

    JGH: Thymosin β10 (TMSB10) can be used as a potential prognostic biomarker for the aggressiveness of gastric cancer

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Gastric cancer (GC) is the second highest incidence of malignant tumors in China and remains one of the leading causes of cancer-related deaths in developing countries


     


    Blood vessel

     


    Figure: The distribution of thymosin β10 (TMSB10) in the body



     

    Original source:

    ZhenKun Yan.


    TMSB10 can serve as a potential prognosis prediction biomarker and promotes the invasion and angiogenesis of gastric cancer.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.